Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 89033787

CD3E Mouse anti-Human, Clone: 33-2A3 (Biotin), Abnova™

Catalog No. 89033787 Shop All Abnova Corporation Products
Change view
Click to view available options
Quantity:
100 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
89-033-787 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 89-033-787 Supplier Abnova Corporation Supplier No. MAB13722
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

Mouse monoclonal antibody raised against human CD3E.

  • High specificity
  • High reactivity

Specifications

Antigen CD3E
Applications Flow Cytometry
Classification Monoclonal
Clone 33-2A3
Conjugate Biotin
Description Mouse monoclonal antibody raised against human CD3E.
Dilution Flow Cytometry (1 ug/106 cells) The optimal working dilution should be determined by the end user.
Formulation In PBS, pH 7.4 (protein stabilizer, 0.09% sodium azide).
Gene Accession No. P07766
Gene Alias FLJ18683/T3E/TCRE
Gene Symbols CD3E
Host Species Mouse
Immunogen Human leukocytes.
Purification Method Protein A/G purification
Quantity 100 μg
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 916
Target Species Human
Content And Storage Store in the dark at 4°C. Avoid prolonged exposure to light.
Form Liquid
Isotype IgG2a
Show More Show Less

For Research Use Only (RUO)

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.